SARS-CoV-2 escapes CD8 T cell surveillance via mutations in MHC-I restricted epitopes
Abstract
CD8+ T cell immunity to SARS-CoV-2 has been implicated in COVID-19 severity and virus control, though direct evidence has been lacking so far. Here, we identified non-synonymous mutations in MHC-I restricted CD8+ T cell epitopes after deep sequencing of 747 SARS-CoV- 2 virus isolates. Mutant peptides exhibited diminished or abrogated MHC-I binding, which was associated with a loss of recognition and functional responses by CD8+ T cells isolated from HLA-matched COVID-19 patients. Our findings highlight the capacity of SARS-CoV-2 to subvert CD8+ T cell surveillance through escape mutations in MHCI-restricted viral epitopes. This provides evolutionary evidence for CD8+ T cell immunity controlling SARS-CoV-2 with consequences for COVID-19 vaccine design.
Competing Interest Statement
The authors have declared no competing interest.
Subject Area
- Biochemistry (11760)
- Bioengineering (8762)
- Bioinformatics (29229)
- Biophysics (14991)
- Cancer Biology (12114)
- Cell Biology (17423)
- Clinical Trials (138)
- Developmental Biology (9432)
- Ecology (14190)
- Epidemiology (2067)
- Evolutionary Biology (18318)
- Genetics (12253)
- Genomics (16809)
- Immunology (11877)
- Microbiology (28110)
- Molecular Biology (11609)
- Neuroscience (61034)
- Paleontology (452)
- Pathology (1873)
- Pharmacology and Toxicology (3239)
- Physiology (4967)
- Plant Biology (10431)
- Synthetic Biology (2888)
- Systems Biology (7346)
- Zoology (1653)